NervGen Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; NervGen Pharma is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	C$ 0.00
Gross Profit	-	-	-	-	-
EBIT	C$ -4.30M	C$ -4.76M	C$ -4.71M	C$ -7.94M	C$ -2.98M
EBITDA	C$ -4.27M	C$ -4.73M	C$ -4.67M	-	C$ -2.95M
Net Income Common Stockholders	C$ -4.30M	C$ -4.76M	C$ -4.71M	-	C$ -3.50M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 14.79M	C$ 16.08M	C$ 18.02M	C$ 22.45M	C$ 27.70M
Total Assets	C$ 16.36M	C$ 17.42M	C$ 19.10M	C$ 23.88M	C$ 28.88M
Total Debt	C$ 219.24K	C$ 240.97K	C$ 262.37K	C$ 283.45K	C$ 304.23K
Net Debt	C$ -14.57M	C$ -15.84M	C$ -17.76M	C$ -22.17M	C$ -27.40M
Total Liabilities	C$ 11.25M	C$ 9.86M	C$ 9.22M	C$ 10.41M	C$ 10.47M
Stockholders Equity	C$ 5.11M	C$ 7.56M	C$ 9.88M	C$ 13.46M	C$ 18.41M
Cash Flow	-
Free Cash Flow	C$ -1.57M	C$ -2.00M	C$ -4.78M	C$ -5.15M	C$ -4.81M
Operating Cash Flow	C$ -1.43M	C$ -2.00M	C$ -4.78M	-	C$ -4.81M
Investing Cash Flow	C$ -138.46K	C$ -2.94K	C$ 2.55K	-	C$ -5.72K
Financing Cash Flow	C$ 72.38K	C$ 253.86K	C$ 365.27K	-	C$ 19.87M

Currency in CAD

NervGen Pharma Earnings and Revenue History

Income Statement >

NervGen Pharma Debt to Assets

Balance Sheet >

NervGen Pharma Cash Flow

Cash Flow >

NervGen Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing